Track topics on Twitter Track topics that are important to you
Long-acting cabotegravir with an 8-week dosing schedule is effective for the prevention of HIV in men and women, new research shows, but will it be embraced by people looking for long-term protection?
Medscape Medical News
Original Article: Cabotegravir-LA Safe in Women, Challenges RemainNEXT ARTICLE
Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...